Association between plasma proteome profiles analysed by mass spectrometry, a lymphocyte-based DNA-break repair assay and radiotherapy-induced acute mucosal reaction in head and neck cancer patients

References

• Azad NS, Rasool N, Annunziata CM, Minasian L, Whiteley G, Kohn EC. 2006. Proteomics in clinical trials and practice. Molecular and Cellular Proteomics 5:1819–1829.
   PubMed Web of Science ®Google Scholar
• Bentzen SM. 2008. From cellular to high-throughput predictive assays in radiation oncology: Challenges and opportunities. Seminars in Radiation Oncology 18:75–88.
   PubMed Web of Science ®Google Scholar
• Bourhis J, Etessami A, Wilbault P, Lusinchi A, Calais G, Lapeyre M, Pignon JP. 2004a. Altered fractionated radiotherapy in the management of head and neck carcinomas: Advantages and limitations. Current Opinion in Oncology 16:215–219.
   PubMed Web of Science ®Google Scholar
• Bourhis J, Calais G, Lapeyre M, Tortochaux, Alfonsi M, Sire C, Bardet E, Rives M, Bergerot P, Rhein B, Desprez B. 2004b. Concomitant radiochemotherapy or accelerated radiotherapy: Analysis of two randomized trials of the French Head and Neck Cancer Group (GORTEC). Seminars in Oncology 31:822–826.
   PubMed Web of Science ®Google Scholar
• Cheng AJ, Chen LC, Chien KY, Chen YJ, Chang JTC, Wang HM, Liao CT, Chen IH. 2005. Oral cancer plasma tumor marker identified with bead-based affinity-fractionated proteomic technology. Clinical Chemistry 51:2236–2244.
   PubMed Web of Science ®Google Scholar
• Cho WCS, Yip TTC, Yip C, Yip V, Thulasiraman V, Ngan RKC, Yip TT, Lau WH, Au JSK, Law SCK, Cheng WW, Ma VWS, Lim CKP. 2004. Identification of serum amyloid A protein as a potentially useful biomarker to monitor relapse of nasopharyngeal cancer by serum proteomic profiling. Clinical Cancer Research 10:43–52.
   PubMed Web of Science ®Google Scholar
• Cho WC. 2007a. Contribution of oncoproteomics to cancer biomarker discovery. Molecular Cancer 6:e25.
   PubMed Web of Science ®Google Scholar
• Cho WC. 2007b. Proteomics technologies and challenges. Genomics Proteomics Bioinformatics 5:77–85.
   PubMedGoogle Scholar
• Cho WC, Cheng CH. 2007. Oncoproteomics: Current trends and future perspectives. Expert Review of Proteomics 4:401–410.
   PubMed Web of Science ®Google Scholar
• Collins AR, Dusinska M, Franclin M, Somorovska M, Petrovska H, Duthie S, Fillion L, Panayiotidis M, Raslova K, Vaughan N. 1997. Comet assay in human biomonitoring studies: Reliability, validation and applications. Environmental and Molecular Mutagenesis 30:139–146.
   PubMed Web of Science ®Google Scholar
• Conrads TP, Hood BL, Issaq HJ, Veenstra TD. 2004. Proteomic patterns as a diagnostic tool for early-stage cancer: A review of its progress to a clinically relevant tool. Molecular Diagnostics 8:77–85.
   Google Scholar
• Dische S. 1994. The uniform reporting of treatment-related morbidity. Seminars in Radiation Oncology 4:112–118.
   PubMedGoogle Scholar
• Dworzanski JP, Snyder AP. 2005. Classification and identification of bacteria using mass spectrometry-based proteomics. Expert Review of Proteomics 2:863–878.
   PubMed Web of Science ®Google Scholar
• Epstein JB, Schubert MM. 2003. Oropharyngeal mucositis in cancer therapy. Oncology 17:1767–1779.
   PubMedGoogle Scholar
• Freed GL, Cazares LH, Fichandler CE, Fuller TW, Sawyer CA, Stack BC Jr, Schraff S, Semmes OJ, Wadsworth JT, Drake RR. 2008. Differential capture of serum proteins for expression profiling and biomarker discovery in pre- and post-treatment head and neck cancer samples. Laryngoscope 118:61–68.
   PubMed Web of Science ®Google Scholar
• Gourin CG, Moretz WH, Weinberger PM, Xia ZS, Liu Z, Terris DJ, Adam BL. 2007. Serum protein profile analysis following definitive treatment in patients with head and neck squamous cell carcinoma. Archives of Otolaryngology Head and Neck Surgery 133:1125–1130.
   PubMedGoogle Scholar
• Gourin CG, Zhi W, Adam BL. 2009. Proteomic identification of serum biomarkers for head and neck cancer surveillance. Laryngoscope 119:1291–302.
   PubMed Web of Science ®Google Scholar
• Green M, Low J, Harcourt SA, Akinluyi P, Row T, Cole J, Anstey AV, Arlett CV. 1992. UV-C sensitivity of unstimulated and stimulated human lymphocytes from normal and Xeroderma pigmentosum donors in the comet assay: A potential diagnostic technique. Mutation Research 273:137–144.
   PubMed Web of Science ®Google Scholar
• Hanash S. 2003. Disease proteomics. Nature 422:226–232.
   PubMed Web of Science ®Google Scholar
• Hastie T, Tibshirani R, Friedman JH. 2001. The elements of statistical learning. New York; Springer Verlag.
   Google Scholar
• Hilario M, Kalousis A, Pellegrini C, Müller M. 2006. Processing and classification of protein mass spectra. Mass Spectrometry Review 25:409–449.
   PubMed Web of Science ®Google Scholar
• Karpievitch YV, Hill EG, Smolka AJ, Morris JS, Coombes KR, Baggerly KA, Almeida JS. 2007. PrepMS: TOF MS data graphical preprocessing Tool. Bioinformatics 23:264–265.
   PubMed Web of Science ®Google Scholar
• Lehrer RI, Ganz T, Selsted ME. 1991. Defensins: Endogenous antibiotic peptides of animal cells. Cell 64:229–230.
   PubMed Web of Science ®Google Scholar
• Li L, Tang H, Wu Z, Gong J, Gruidl M, Zou J, Tockman M, Clark RA. 2004. Data mining techniques for cancer detection using serum proteomic profiling. Artificial Intelligence in Medicine 32:71–83.
   PubMed Web of Science ®Google Scholar
• Liotta LA, Ferrari M, Petricoin EF. 2003. Clinical proteomics: Written in blood. Nature 425:905.
   PubMed Web of Science ®Google Scholar
• Liotta LA, Petricoin EF. 2006. Serum peptidome for cancer detection: Spinning biological trash into diagnostic gold. Journal of Clinical Investigations 116:26–30.
   PubMed Web of Science ®Google Scholar
• Lustgarten JL, Kimmel C, Ryberg H, Hogan W. 2008. EPO-KB: A searchable knowledge base of biomarker to protein links. Bioinformatics 24:1418–1419.
   PubMed Web of Science ®Google Scholar
• Mbikay M, Seidah NG, Chretien M. 2001. Neuroendocrine secretory protein 7B2: Structure, expression and functions. Biochemical Journal 357:329–342.
   PubMed Web of Science ®Google Scholar
• Menard C, Johann D, Lowenthal M, Muanza T, Sproull M, Ross S, Gulley J, Petricoin E, Coleman CN, Whiteley G, Liotta L, Camphausen K. 2006. Discovering clinical biomarkers of ionizing radiation exposure with serum proteomic analysis. Cancer Research 66:1844–1850.
   PubMed Web of Science ®Google Scholar
• Nuyten DS, van de Vijver MJ. 2008. Using microarray analysis as a prognostic and predictive tool in oncology: Focus on breast cancer and normal tissue toxicity. Seminars in Radiation Oncology 18:105–114.
   PubMed Web of Science ®Google Scholar
• Oppitz U, Schulte S, Stopper H, Baier K, Muller M, Wulf J, Schakowski R, Flentje M. 2002. In vitro radiosensitivity measured in lymphocytes and fibroblasts by colony formation and comet assay: Comparison with clinical acute reactions to radiotherapy in breast cancer patients. International Journal of Radiation Biology 78:611–616.
   PubMed Web of Science ®Google Scholar
• Palmblad M, Tiss A, Cramer R. 2009. Mass spectrometry in clinical proteomics – from the present to the future. Proteomics Clinical Applications 3:6–17.
   PubMed Web of Science ®Google Scholar
• Palyvoda O, Polanska J, Wygoda A, Rzeszowska-Wolny J. 2003. DNA damage and repair in lymphocytes of normal individuals and cancer patients: Studies by the comet assay and micronucleus tests. Acta Biochimica Polononica 50:181–190.
   PubMed Web of Science ®Google Scholar
• Pietrowska M, Marczak L, Polanska J, Behrendt K, Nowicka E, Walaszczyk A, Chmura A, Deja R, Stobiecki M, Polanski A, Tarnawski R, Widlak P. 2009. Mass spectrometry-based serum proteome pattern analysis in molecular diagnostics of early stage breast cancer. Journal of Translational Medicine 7:e60.
   PubMed Web of Science ®Google Scholar
• Popanda O, Ebbeler R, Twardella D, Helmbold I, Gotzes F, Schmezer P, Thielmann HW, von Fournier D, Haase W, Sautter-Bihl ML, Wenz F, Bartsch B, Chang-Claude J. 2003. Radiation-induced DNA damage and repair in lymphocytes from breast cancer patients and their correlation with acute skin reactions to radiotherapy. International Journal of Radiation Oncology Biology and Physics 55:1216–1225.
   PubMed Web of Science ®Google Scholar
• Posadas EM, Simpkins F, Liotta LA, MacDonald C, Kohn EC. 2005. Proteomic analysis for the early detection and rational treatment of cancer-realistic hope? Annals of Oncology 16:16–22.
   PubMed Web of Science ®Google Scholar
• Schaaij-Visser TB, Brakenhoff RH, Leemans CR, Heck AJ, Slijper M. 2010. Protein biomarker discovery for head and neck cancer. Journal of Proteomics 73:1790–803.
   PubMed Web of Science ®Google Scholar
• Schölkopf B, Smola AJ, Williamson RC, Bartlett PL. 2000. New Support Vector algorithms. Neural Computation 12:1207–1245.
   PubMed Web of Science ®Google Scholar
• Solassol J, Jacot W, Lhermitte L, Boulle N, Maudelonde T, Mangé A. 2006. Clinical proteomics and mass spectrometry profiling for cancer detection. Expert Review of Proteomics 3:311–320.
   PubMed Web of Science ®Google Scholar
• Soltys SG, Le QT, Shi G, Tibshirani R, Giaccia AJ, Koong AC. 2004. The use of plasma surface-enhanced laser desorption/ionization time-of-flight mass spectrometry proteomic patterns for detection of head and neck squamous cell cancers. Clinical Cancer Research 10:4806–4812.
   PubMed Web of Science ®Google Scholar
• Somorjai RL. 2008. Pattern recognition approaches for classifying proteomic mass spectra of biofluids. Methods in Molecular Biology 428:383–396.
   PubMedGoogle Scholar
• Sonis ST. 2004. The pathobiology of mucositis. Nature Review Cancer 4:277–284.
   PubMed Web of Science ®Google Scholar
• Treister N, Sonis S. 2007. Mucositis: Biology and management. Current Opinion in Otolaryngology Head and Neck Surgery 15:123–129.
   PubMedGoogle Scholar
• Vera-Llonch M, Oster G, Hagiwara M, Sonis S. 2006. Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma. Cancer 106:329–336.
   PubMed Web of Science ®Google Scholar
• Wadsworth JT, Komers KD, Cazares LH, Malik G, Adam BL, Stack BC, Wright GL, Semmes OJ. 2004. Serum protein profiles to identify head and neck cancer. Clinical Cancer Research 10:1625–1632.
   PubMed Web of Science ®Google Scholar
• Wang WD, Chen ZT, Li DZ, Cao ZH, Sun SL, Pu P, Chen XP. 2005. Correlation between DNA repair capacity in lymphocytes and acute side effects to skin during radiotherapy in nasopharyngeal cancer patients. Clinical Cancer Research 11:5140–5145.
   PubMed Web of Science ®Google Scholar
• WoutersBG. 2008. Proteomics: Methodologies and applications in oncology. Seminars in Radiation Oncology18:115–125.
   PubMed Web of Science ®Google Scholar
• WulfkuhleJD, LiottaLA, PetricoinEF. 2003. Proteomic applications for the early detection of cancer. Nature Review Cancer3:267–275.
   PubMed Web of Science ®Google Scholar
• WygodaA, MaciejewskiB, SkładowskiK, HutnikM, PileckiB, GoleńM, RutkowskiT. 2009. Pattern analysis of acute mucosal reactions in patients with head and neck cancer treated with conventional and accelerated irradiation. International Journal of Radiation Oncology Biology and Physics73:384–390.
   PubMed Web of Science ®Google Scholar